Malaria vaccin
3 juni 2024 2024-07-26 10:24Malaria vaccin
Research into a malaria vaccine | CoGA study
For several years, the Leiden University Medical Center (LUMC) is doing research into the development of a malaria vaccine. Malaria is a tropical infectious disease that can be fatal. Every year, many children still die as a result of malaria, especially in Africa. An effective malaria vaccine could prevent many of those deaths.
The LUMC has developed the GA2-parasite. The GA2 is an attenuated parasite that cannot cause malaria, but can induce protection (immunity) against malaria. Previous research in the LUMC has shown that administration of the GA2 through mosquito bites is safe. After three immunizations with the GA2, 89% of the participants was protected against a controlled malaria infection. We hope that the GA2 can be used as a vaccine in the future.
In the CoGA study, we want to study how well the GA2 induces protection after one administration.
Who are we looking for? Healthy people aged 18 to 35 years
Additional information
Sign up
Provide your contact details on this web page and we will contact you to plan a screening visits in the LUMC without any obligations. During this visit we will inform you on the trial and decide whether you are eligible for participation.
For further questions, you can contact the researchers
Vincent van Kraaij
Prof. dr. Meta Roestenberg, internist-infectious disease specialist
Tel: 06-20942061